These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9165222)

  • 1. Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance.
    Turpeinen AK; Kuikka JT; Vanninen E; Uusitupa MI
    Diabetologia; 1997 May; 40(5):541-9. PubMed ID: 9165222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of disturbed free fatty acid metabolism of myocardium in patients with non-insulin-dependent diabetes mellitus as measured with iodine-123-heptadecanoic acid.
    Kuikka JT; Mustonen JN; Uusitupa MI; Rautio P; Vanninen E; Laakso M; Länsimies E; Pyörälä K
    Eur J Nucl Med; 1991; 18(7):475-81. PubMed ID: 1915474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
    Knuuti J; Takala TO; Någren K; Sipilä H; Turpeinen AK; Uusitupa MI; Nuutila P
    Diabetologia; 2001 Feb; 44(2):184-7. PubMed ID: 11270674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
    Turpeinen AK; Takala TO; Nuutila P; Axelin T; Luotolahti M; Haaparanta M; Bergman J; Hämäläinen H; Iida H; Mäki M; Uusitupa MI; Knuuti J
    Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.
    Turpeinen AK; Vanninen E; Kuikka JT; Uusitupa MI
    Diabetes Care; 1996 Oct; 19(10):1083-90. PubMed ID: 8886553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.
    Peterson LR; Herrero P; McGill J; Schechtman KB; Kisrieva-Ware Z; Lesniak D; Gropler RJ
    Diabetes; 2008 Jan; 57(1):32-40. PubMed ID: 17914030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [123I-beta-methyl-iodophenyl-pentadecanoic acid myocardial scintigraphy in diabetic patients without overt ischemic heart disease].
    Shinmura K; Tani M; Suganuma Y; Hasegawa H; Kawamura M; Nakamura Y; Hashimoto J; Kubo A
    J Cardiol; 1995 Jul; 26(1):23-32. PubMed ID: 7666341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans.
    Labbé SM; Grenier-Larouche T; Noll C; Phoenix S; Guérin B; Turcotte EE; Carpentier AC
    Diabetes; 2012 Nov; 61(11):2701-10. PubMed ID: 23093657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
    Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
    Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease.
    Avogaro A; Nosadini R; Doria A; Fioretto P; Velussi M; Vigorito C; Saccà L; Toffolo G; Cobelli C; Trevisan R
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E606-18. PubMed ID: 2333960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.
    Herrero P; Peterson LR; McGill JB; Matthew S; Lesniak D; Dence C; Gropler RJ
    J Am Coll Cardiol; 2006 Feb; 47(3):598-604. PubMed ID: 16458143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sex and Impaired Glucose Tolerance on Organ-Specific Dietary Fatty Acid Metabolism in Humans.
    Kunach M; Noll C; Phoenix S; Guérin B; Baillargeon JP; Turcotte EE; Carpentier AC
    Diabetes; 2015 Jul; 64(7):2432-41. PubMed ID: 25503741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial metabolism with iodine-123 heptadecanoic acid: effect of decreased fatty acid oxidation on deiodination.
    Lüthy P; Chatelain P; Papageorgiou I; Schubiger A; Lerch RA
    J Nucl Med; 1988 Jun; 29(6):1088-95. PubMed ID: 3373317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus.
    Niskanen L; Sarlund H; Laakso M
    Metabolism; 1995 Aug; 44(8):1099-104. PubMed ID: 7637652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose tolerance and insulin response in parents of patients with insulin-dependent and juvenile-onset non-insulin-dependent diabetes mellitus.
    Matsuda A; Kuzuya T
    Diabetes Res Clin Pract; 1992 Apr; 16(1):37-46. PubMed ID: 1576930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus.
    Hattori N; Tamaki N; Kudoh T; Masuda I; Magata Y; Kitano H; Inubushi M; Tadamura E; Nakao K; Konishi J
    J Nucl Med; 1998 Nov; 39(11):1835-40. PubMed ID: 9829566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac metabolism in patients with insulin-dependent diabetes without coronary atherosclerosis].
    Avogaro A; Nosadini R
    Cardiologia; 1991 Apr; 36(4):273-85. PubMed ID: 1933958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
    Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.